Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age

Cancer

Volumn 119, Issue 22, 2013, Pages 3959-3967

  O'Meara, Ellen S ^a   Zhu, Weiwei ^a   Hubbard, Rebecca A ^a,b   Braithwaite, Dejana ^c   Kerlikowske, Karla ^c,d   Dittus, Kim L ^e   Geller, Berta ^e   Wernli, Karen J ^a   Miglioretti, Diana L ^a,f  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

breast cancer; ethnicity; mammography; race; screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASIAN; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; FALSE POSITIVE RESULT; FEMALE; HIGH RISK POPULATION; HISPANIC; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEGRO; PRIORITY JOURNAL; RACE; RISK ASSESSMENT;

BREAST CANCER; ETHNICITY; MAMMOGRAPHY; RACE; SCREENING;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS; UNITED STATES;

EID: 84887077532     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28310     Document Type: Article

References (31)

1. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster V,. Efficacy of screening mammography: a meta-analysis. JAMA. 1995; 273: 149-154.
2. Wai ES, D'yachkova Y, Olivotto IA, et al. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer. 2005; 92: 961-966.
3. White E, Miglioretti DL, Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst. 2004; 96: 1832-1839.
4. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009; 151: 738-747.
5. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL,. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011; 155: 481-492.
6. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L,. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151: 727-737.
7. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151: 716-726; W-236.
8. Kerlikowske K,. Evidence-based breast cancer prevention: the importance of individual risk. Ann Intern Med. 2009; 151: 750-752.
9. Li CI, Malone KE, Daling JR,. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003; 163: 49-56.
10. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2012. seer.cancer.gov/csr/1975-2009-pops09/. Accessed December 17, 2012.
11. DeLancey JO, Thun MJ, Jemal A, Ward EM,. Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2908-2912.
12. Menashe I, Anderson WF, Jatoi I, Rosenberg PS,. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst. 2009; 101: 993-1000.
13. Martin N, Wingfield J,. USPSTF screening recommendations for breast cancer: the potential impact on the African American community. J Health Care Poor Underserved. 2012; 23 (suppl 2): 91-97.
14. Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997; 169: 1001-1008.
15. American College of Radiology. The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). 4th ed. Reston, VA: American College of Radiology; 2003.
16. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
17. Hubbard R, Miglioretti D, Smith R,. Modeling the cumulative risk of a false-positive screening test. Stat Methods Med Res. 2010; 19: 429-449.
18. Ademuyiwa FO, Edge SB, Erwin DO, Orom H, Ambrosone CB, Underwood W 3rd,. Breast cancer racial disparities: unanswered questions. Cancer Res. 2011; 71: 640-644.
19. van Ravesteyn NT, Schechter CB, Near AM, et al. Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev. 2011; 20: 112-122.
20. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005; 97: 439-448.
21. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006; 144: 541-553.
22. Clarke CA, Keegan TH, Yang J, et al. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst. 2012; 104: 1094-1101.
23. Kerlikowske K, Creasman J, Leung JW, Smith-Bindman R, Ernster VL,. Differences in screening mammography outcomes among White, Chinese, and Filipino women. Arch Intern Med. 2005; 165: 1862-1868.
24. Gill KS, Yankaskas BC,. Screening mammography performance and cancer detection among black women and white women in community practice. Cancer. 2004; 100: 139-148.
25. Yankaskas BC, Gill KS,. Diagnostic mammography performance and race: outcomes in Black and White women. Cancer. 2005; 104: 2671-2681.
26. Goldman LE, Haneuse SJ, Miglioretti DL, et al. An assessment of the quality of mammography care at facilities treating medically vulnerable populations. Med Care. 2008; 46: 701-708.
27. Goldman LE, Walker R, Miglioretti DL, Smith-Bindman R, Kerlikowske K,; National Cancer Institute Breast Cancer Surveillance Consortium. Accuracy of diagnostic mammography at facilities serving vulnerable women. Med Care. 2011; 49: 67-75.
28. Strzelczyk JJ, Dignan MB,. Disparities in adherence to recommended follow-up on screening mammography: interaction of sociodemographic factors. Ethn Dis. 2002; 12: 77-86.
29. Autier P, Hery C, Haukka J, Boniol M, Byrnes G,. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol. 2009; 27: 5919-5923.
30. Zelen M, Feinleib M,. On the theory of screening for chronic diseases. Biometrika. 1969; 56: 601-614.
31. Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011; 155: 493-502.